Has Mark Ramirez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $341 in general payments to Mark Ramirez, MD across 11 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Ramirez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Ramirez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Ramirez, MD

Dermatology · San Angelo, TXNPI 1639373210

Payments from drug & device makers

$341in general payments, 2019–2025

Across 11 payments — averaging $30.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$232
AbbVie$47
UCB, Inc.$35
Lilly USA, LLC$26

What the payments were for

Food & beverage$341100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	5	$232
AbbVie	2	$47
UCB, Inc.	2	$35
Lilly USA, LLC	2	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$122

How this compares

$341 in reported general payments places this provider in the 15th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024

$534,909

Medicare patients

1,090

Services billed

9,131

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab	19	$161,595
SotyktuDeucravacitinib	11	$68,239
Fluocinonide	99	$5,398
Ketoconazole	256	$4,529
Clobetasol Propionate	59	$2,605
Imiquimod	80	$1,709
Fluorouracil	26	$1,614
Doxycycline Hyclate	150	$1,604
Triamcinolone Acetonide	189	$1,549
Tacrolimus	12	$945
Cephalexin	134	$613
ValacyclovirValacyclovir Hcl	45	$540
Hydroxychloroquine Sulfate	23	$513
Metronidazole	15	$504
MethotrexateMethotrexate Sodium	48	$431

Paid to pharmacies, not to this prescriber.

Other dermatology in San Angelo

Stephen TyringWebster$14.1M
Edward LainAustin$12M
Mark LeeSan Antonio$10.9M
John BrowningSan Antonio$10.7M
Craig TellerBellaire$7.7M
Patricia LeeWebster$7.2M
Jennifer CatherDallas$4.9M
Michael MigdenHouston$3.7M
Martin MenterDallas$3.7M
Janet DuboisAustin$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →